Pain Care Labs Named Rising Star in Pharmacy Industry

Leading pharmacy industry publication Drug Store News has awarded Pain Care Labs the “Rising Star” award for the successful pharmacy launch of its VibraCool® and Buzzy® products. CEO Amy Baxter MD FAAP FACEP will exhibit these pharmacy products and physiotherapy pain relief devices at Arab Health 2023. The “Rising Star” award acknowledged Dr. Baxter’s research, dedication, and inventions that have improved diabetes compliance and vaccination rates around the world, as well as improving mobility and pain relief with the vibrating cryotherapy musculoskeletal (MSK) line. At Arab Health 2023, the Company debuts its market-ready, clinical solutions for dialysis, regenerative medicine, and MSK recovery.

“I am grateful for the award and the recognition of our work to improve healthcare, including expanding vaccination uptake and developing MSK pain relief options,” says Dr. Baxter. “I’ve researched pain for over 20 years. We continue to learn about how the brain processes pain and how certain physical and mechanical interventions - including the neuromodulation platform I invented in 2006 - can help reduce pain and fear.”

Our shared understanding of the brain science of pain has led to transformative opportunities in just the last few years. Recent learnings demonstrate why Pain Care Labs’ patented mechanical stimulation (M-Stim®) works to reduce pain, and why electric stimulation is not effective. At Arab Health 2023, the Company introduces its market-ready VibraCool® PRO for physiotherapy pain relief. Its novel mechanical CryoVibration™ is designed for post-surgical recovery, restricted muscles, and overuse injuries.

DuoTherm™, the Company’s device to eliminate or reduce low back pain and surgeries, is a rigid brace with multimodal pain relief options and thermal frequencies. Available in 2024, the device reduced pain 57% in an NIH funded Phase 1, and is expected to disrupt the spine industry.

The Company also introduces its market-ready Buzzy® PRO platform. While 28% of adults fear needles, and fainting can be a genetic response regardless of fear, almost 100% of dialysis patients resent the needle. Buzzy® PRO’s updated design is contoured with special ice packs to cover a larger surface area than our original bee-shaped Buzzy®. The PRO is your in-office needle pain solution for diabetes, dialysis, electrolysis, IV access, dry needling, and regenerative medicine.

About Pain Care Labs & Amy Baxter MD FAAP FACEP

Amy Baxter MD FAAP FACEP established Pain Care Labs in 2006. Dr. Baxter is an emergency physician and pain researcher whose mission is to eliminate unnecessary pain. The Company's award-winning mechanical stimulation (M-Stim®) solutions are FDA-registered, 510K cleared. Buzzy®, VibraCool®, and PRO are based on a patented Oscillice® neuromodulation platform using mechanical stimulation and ice to give serious, simple relief. Pain Care Labs is the leading innovator in mechanical stimulation (M-Stim®)  therapies. The Company’s proprietary (M-Stim®) vibration platform now includes clinical pain solutions.

With over 85 studies establishing efficacy, Buzzy® has been used to block pain from over 45 million needle procedures. Evolving understandings of pain led Dr. Baxter to expand the platform to include MSK solutions, called VibraCool®. The Company’s needle and MSK solutions now include “PRO” options for clinicians. For more information visit PainCareLabs.com or in person at the show, booth # H1.G50.